FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / News / Read News

Print

Oakworth Capital Bank Finances Facility Supporting Navis Clinical Laboratories’ Purchase of Lab Business

March 08, 2023, 07:30 AM
Filed Under: Medical

Oakworth Capital Bank acted as servicer and sole agent for a senior secured credit facility that supports the Navis Clinical Laboratories purchase of the clinical laboratory business of Cordant Health Solutions. Proceeds from the financing were used to fund the acquisition, as well support Navis' ongoing working capital needs.

Oakworth Commercial Banking Advisor Terrell Taylor organized the team on behalf of the bank. Taylor's long-tenured experience in serving the healthcare industry played a key role in providing Navis with a seamless, easy experience, based on expert advice.

"We are fortunate to have Oakworth as a key advisor and banking partner as we build our lab company."

"This transaction displays Oakworth's unique ability to leverage our healthcare expertise and streamlined diligence and credit process to help provide debt capital to companies like Navis," said Taylor. "We are pleased to invest in such a strong and experienced management team that possesses a great reputation and track record of success in the lab space."

Navis President and CEO Richard Stripp, Ph. D. added, "At the onset, Oakworth assured us of their ability to move quickly and showed real flexibility during negotiations and closing. We appreciate the efficient and transparent way in which Oakworth worked with us. We are fortunate to have them as a key advisor and banking partner as we build our lab company."

Navis, headquartered in Franklin, Tenn., provides innovative solutions tailored for healthcare providers who treat patients with substance use disorder, chronic pain, mental health conditions and other chronic health conditions. Its proprietary, patented medication-monitoring tool, CORE (Comprehensive Oral Fluid Rx Evaluation), uses saliva samples to help providers determine if medication is present at a steady-state level consistent with the prescribed dosing regimen or if there are metabolic or health issues that need more investigation. The company currently has three laboratories located in New York, Massachusetts and Washington and serves clients throughout the United States.








Week's News



Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.